Benzyl Lysine Eye Drops

This product is an aldose reductase (AR) inhibitor. Literature reports show that it has an inhibitory effect on lens aldose reductase (AR). Therefore, benzyl dazine (BDZL) eye drops are used to inhibit the activity of AR in the eye to achieve the purpose of preventing or treating cataracts.

The main ingredients of this product and their chemical names: The main ingredient is benzalkonium lysine, the chemical name is L-lysine (1-benzyl-1H-indazole-3-oxyl) acetate, its molecular formula: C6H14N2O2C16H14N2O3, molecular weight: 428.46.

This product is a colorless or slightly yellow clear liquid.

Early stage senile cataract.

3 times a day, 1 to 2 drops each time.

There may be transient burning sensation, tearing and other reactions, but they can be adapted to as the medication time is extended. Rarely, there may be dysphagia, nausea, vomiting, diarrhea, tearing, contact dermatitis, etc.

1. Do not use if you are allergic to this product. 2. Do not use in case of eye injury or severe infection, or follow the doctor's advice.

Precautions for children: Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly:

If you are using other medicines, please consult your physician or pharmacist before using this product.

Keep away from light and store in airtight container.

8 ml: 40 mg

36 months

Ebe Pharmaceutical Co., Ltd.

• Founded in:

  2003-12-18

• Address:

  No. 28, High-tech Industrial Park, Wuhan Economic and Technological Development Zone

• Tax NO.:

  91420000757010980Y

• Registered Funds:

  114 million yuan

• Website:

  Log in to view

• Email:

  Log in to view